PT1515732E - Protecção cerebral com um gás compreendendo xénon - Google Patents

Protecção cerebral com um gás compreendendo xénon Download PDF

Info

Publication number: PT1515732E
Authority: PT; Portugal
Prior art keywords: cerebral; xenon; impairments; protection; cerebral protection
Prior art date: 2002-06-12

Application number

PT03759935T

Other languages

English (en)

Inventor

Peter Neu

Matthias Reyle-Hahn

Carsten Pilger

Original Assignee

Air Liquide Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-12

Filing date

2003-06-12

Publication date

2009-04-14

2003-06-12 Application filed by Air Liquide Deutschland Gmbh filed Critical Air Liquide Deutschland Gmbh

2009-04-14 Publication of PT1515732E publication Critical patent/PT1515732E/pt

Links

230000002490 cerebral effect Effects 0.000 title abstract 5
229910052724 xenon Inorganic materials 0.000 title abstract 3
FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 title abstract 3
230000006735 deficit Effects 0.000 abstract 3
239000003814 drug Substances 0.000 abstract 2
208000018152 Cerebral disease Diseases 0.000 abstract 1
230000003788 cerebral perfusion Effects 0.000 abstract 1
230000001149 cognitive effect Effects 0.000 abstract 1
239000007789 gas Substances 0.000 abstract 1
230000010412 perfusion Effects 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
230000001953 sensory effect Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Inorganic Chemistry (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

PT03759935T 2002-06-12 2003-06-12 Protecção cerebral com um gás compreendendo xénon PT1515732E (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10226191		2002-06-12
DE10227975		2002-06-22
DE10236765		2002-08-10

Publications (1)

Publication Number	Publication Date
PT1515732E true PT1515732E (pt)	2009-04-14

Family

ID=29740361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT03759935T PT1515732E (pt)	2002-06-12	2003-06-12	Protecção cerebral com um gás compreendendo xénon

Country Status (11)

Country	Link
US (1)	US7235264B2 (pt)
EP (1)	EP1515732B1 (pt)
JP (1)	JP2005533062A (pt)
CN (1)	CN1668315A (pt)
AT (1)	ATE420650T1 (pt)
AU (1)	AU2003246415A1 (pt)
DE (1)	DE50311092D1 (pt)
DK (1)	DK1515732T3 (pt)
ES (1)	ES2321185T3 (pt)
PT (1)	PT1515732E (pt)
WO (1)	WO2003105871A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9526863B2 (en) *	2009-02-08	2016-12-27	Neuronal Protection System, Llc	Devices and methods for perfusion therapy
US8622992B2 (en) *	2009-02-08	2014-01-07	Blaise Baxter	Devices and methods for perfusion therapy
FR2964876B1 (fr) *	2010-09-22	2013-04-12	Air Liquide Sante Int	Composition anesthesique gazeuse a base de xenon utilisable pendant une endarteriectomie avec clampage de l'artere carotide
CN110464709A (zh) *	2012-08-10	2019-11-19	德克萨斯州大学系统董事会	用于治疗中风的神经保护性脂质体组合物和方法
US20160030472A1 (en) *	2013-03-05	2016-02-04	Air Liquide Santé (International)	Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery
WO2014145443A2 (en)	2013-03-15	2014-09-18	The Board Of Regents Of The University Of Texas System	Liquids rich in noble gas and methods of their preparation and use
FR3022456B1 (fr) *	2014-06-20	2016-07-15	Air Liquide	Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
CN112805038A (zh) *	2018-07-18	2021-05-14	悦智有限公司	用于使化合物加速组织穿透到脑内的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1601366A (en)	1977-06-21	1981-10-28	Nat Res Dev	Lasers
FR2538704B1 (fr)	1983-01-03	1986-02-28	France Prod Oxygenes Co	Produit de contraste des images en tomodensitometrie
US5228434A (en) *	1991-07-16	1993-07-20	Praxair Technology, Inc.	Mixture for anesthesia
US5099834A (en)	1991-07-16	1992-03-31	Union Carbide Industrial Gases Technology Corporation	Method for anesthesia
EP0855912B1 (fr) *	1995-10-20	2001-12-05	L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude	Composition a base de monoxyde d'azote en tant que medicament
DE19709704C2 (de)	1997-03-10	1999-11-04	Michael Georgieff	Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19910986C2 (de) *	1999-03-11	2001-06-07	Aga Ab	Verwendung von Xenon bei der Behandlung von Neurointoxikationen
GB9913677D0 (en)	1999-06-11	1999-08-11	Imperial College	Formulation
DE19933704A1 (de) *	1999-07-19	2001-01-25	Michael Georgieff	Verwendung einer lipophile Gase enthaltenden Präparation zur Neuroprotektion und Neuroregeneration
DE19938800A1 (de)	1999-08-16	2001-02-22	Stefan Huebner	Medizinisches Präperat zur Verabreichung flüchtiger Stoffe
FR2812197B1 (fr) *	2000-07-27	2003-01-03	Air Liquide Sante Int	Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2812545B1 (fr)	2000-08-03	2003-03-28	Air Liquide Sante Int	Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
DE10045829A1 (de)	2000-09-14	2002-04-04	Messer Griesheim Gmbh	Volatile Anästhesiemittel mit Xenon
DE10045845A1 (de) *	2000-09-14	2002-04-04	Messer Griesheim Gmbh	Xenon als Arzneimittel
US6596206B2 (en)	2001-03-30	2003-07-22	Picoliter Inc.	Generation of pharmaceutical agent particles using focused acoustic energy

2003
- 2003-06-12 ES ES03759935T patent/ES2321185T3/es not_active Expired - Lifetime
- 2003-06-12 DK DK03759935T patent/DK1515732T3/da active
- 2003-06-12 US US10/517,723 patent/US7235264B2/en not_active Expired - Lifetime
- 2003-06-12 WO PCT/EP2003/006157 patent/WO2003105871A1/de not_active Ceased
- 2003-06-12 CN CNA038165767A patent/CN1668315A/zh active Pending
- 2003-06-12 AU AU2003246415A patent/AU2003246415A1/en not_active Abandoned
- 2003-06-12 EP EP03759935A patent/EP1515732B1/de not_active Expired - Lifetime
- 2003-06-12 AT AT03759935T patent/ATE420650T1/de active
- 2003-06-12 JP JP2004512773A patent/JP2005533062A/ja active Pending
- 2003-06-12 PT PT03759935T patent/PT1515732E/pt unknown
- 2003-06-12 DE DE50311092T patent/DE50311092D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2321185T3 (es)	2009-06-03
WO2003105871A1 (de)	2003-12-24
JP2005533062A (ja)	2005-11-04
US7235264B2 (en)	2007-06-26
US20050255168A1 (en)	2005-11-17
ATE420650T1 (de)	2009-01-15
EP1515732B1 (de)	2009-01-14
DK1515732T3 (da)	2009-05-11
AU2003246415A1 (en)	2003-12-31
DE50311092D1 (de)	2009-03-05
EP1515732A1 (de)	2005-03-23
CN1668315A (zh)	2005-09-14

Similar Documents

Publication	Publication Date	Title
ZA200304310B (en)	2004-09-02	Method and device for the production of concrete.
TW200505434A (en)	2005-02-16	Therapeutic treatment
AU7958701A (en)	2002-02-13	Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
WO2002044187A3 (en)	2002-09-12	Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
AU2002236795A1 (en)	2002-08-12	Compositions and method of tissue superoxygenation
NO944164L (no)	1994-11-01	Fremgangsmåte for fremstilling og anvendelse av en HCl-adsorbent
AU2003246415A1 (en)	2003-12-31	Cerebral protection with a gas comprising xenon
NZ530037A (en)	2006-03-31	Use of glycosaminoglycans for the treatment of HIV-associated nephropathy
JOP20220179A1 (ar)	2023-01-30	N4-هيدروكسي سيتيدين ومشتقات واستخدامات مضادة للفيروسات مرتبطة بها
WO2004006859A3 (en)	2004-07-01	Platinum compound
GB0406384D0 (en)	2004-04-21	Composition for reducing appetite in mammals comprising proxyanidin
MXPA05001885A (es)	2005-06-03	El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
EP1719515A3 (en)	2006-11-29	Glycyrrhizin or derivatives thereof for treating or preventing togavirus infections
WO2001089536A3 (en)	2002-08-01	Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
AP2002002446A0 (en)	2002-03-31	Method for administering a phosphodiesterase 4 inhibitor.
NO20062462L (no)	2006-07-28	Ventil, saerlig en gassikkerhetsventil
WO2000032177A3 (en)	2001-03-22	Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections
WO2005091987A3 (en)	2006-06-01	Method of treating down syndrome
TW200603785A (en)	2006-02-01	Compositions containing reduced coenzyme Q10 and carotenoid
MXPA03006477A (es)	2004-05-24	Metodo de tratamiento de diabetes tipo i.
AU2001280093A1 (en)	2002-02-25	Method for the prevention and treatment of retinopathy
MXPA05003616A (es)	2006-01-24	Composiciones que comprenden anfotericina b altamente purificada.
PT1703901E (pt)	2008-12-02	Composição farmacêutica
ATE382357T1 (de)	2008-01-15	Analgetikum für neugeborene und föten
FR2849779B1 (fr)	2006-07-14	Utilisation de xenon ou de n2o dans le traitement des deteriorations cellulaires cerebrales post-ischemiques